MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

What is in Trump's new 'Big, Beautiful Bill'? How will the tariff deadlines affect US-EU trade? Why did Del Monte file for bankruptcy? What impact will ending EV tax credits have? How did June's jobs report affect the stock market? Why is OPEC planning another oil output hike? What caused the surge in US equity fund inflows?

MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

benzinga.com/markets/equities/25/07/46238749/mira-pharmaceuticals-marijuana-analog-mira-55-shows-potent-pain-relief-in-preclinical-study-stoc

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares soared to $1.87, an approximate 50.8% jump, during after-hours trading on Wednesday.
What Happened: After the announcement of Mira-55, a synthetic analog of marijuana, providing pain relief comparable to morphine, the stock value of MIRA…

This story appeared on benzinga.com, 2025-07-03 05:46:06.